Molecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA 92037, USA.
Cell. 2011 May 13;145(4):607-21. doi: 10.1016/j.cell.2011.03.043.
Class IIa histone deacetylases (HDACs) are signal-dependent modulators of transcription with established roles in muscle differentiation and neuronal survival. We show here that in liver, class IIa HDACs (HDAC4, 5, and 7) are phosphorylated and excluded from the nucleus by AMPK family kinases. In response to the fasting hormone glucagon, class IIa HDACs are rapidly dephosphorylated and translocated to the nucleus where they associate with the promoters of gluconeogenic enzymes such as G6Pase. In turn, HDAC4/5 recruit HDAC3, which results in the acute transcriptional induction of these genes via deacetylation and activation of FOXO family transcription factors. Loss of class IIa HDACs in murine liver results in inhibition of FOXO target genes and lowers blood glucose, resulting in increased glycogen storage. Finally, suppression of class IIa HDACs in mouse models of type 2 diabetes ameliorates hyperglycemia, suggesting that inhibitors of class I/II HDACs may be potential therapeutics for metabolic syndrome.
IIa 类组蛋白去乙酰化酶 (HDACs) 是转录的信号依赖性调节剂,在肌肉分化和神经元存活中发挥着重要作用。我们在这里表明,在肝脏中,IIa 类 HDACs(HDAC4、5 和 7)被 AMPK 家族激酶磷酸化并排除在核外。响应禁食激素胰高血糖素,IIa 类 HDACs 迅速去磷酸化并易位到核内,在核内与糖异生酶(如 G6Pase)的启动子结合。反过来,HDAC4/5 招募 HDAC3,通过去乙酰化和激活 FOXO 家族转录因子,导致这些基因的急性转录诱导。在小鼠肝脏中缺失 IIa 类 HDACs 会抑制 FOXO 靶基因并降低血糖,导致糖原储存增加。最后,在 2 型糖尿病小鼠模型中抑制 IIa 类 HDACs 可改善高血糖,这表明 I/II 类 HDAC 抑制剂可能是代谢综合征的潜在治疗药物。